Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 65,456 shares at $18.44 ($1.2M) on 2019-09-16, disclosed to the SEC on 2019-09-18.
Open-market sale of $1.2M ALDR by Managing Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.44 | 32,728 | $604K | 50.0% |
| 2 | $18.44 | 32,728 | $604K | 50.0% |
| Total | $18.44 avg | 65,456 | $1.2M | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |
| ALDR | SELL | 2018-11-05 | $135K | — | Filing → |